All News #Library
Biotech
Prime Shows Only 1 in 12 Stay on GLP-1 Obesity Drug After 3 Yrs
25 Jun 2025 //
PR NEWSWIRE
Prime Therapeutics Announces Cost-Effective Humira Biosimilar
07 Oct 2024 //
PR NEWSWIRE
Prime Finds Only 1 In 7 Patients Stay On GLP-1 Weight Loss Drugs After 2 Years
10 Jul 2024 //
PR NEWSWIRE

Market Place
Sourcing Support